Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2-Radiological features and metric markers - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Critical Reviews in Oncology/Hematology Année : 2021

Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2-Radiological features and metric markers

, , , , , , (1, 2) , ,
1
2

Résumé

After chemoradiotherapy for glioblastoma, pseudoprogression can occur and must be distinguished from true progression to correctly manage glioblastoma treatment and follow-up. Conventional treatment response assessment is evaluated via conventional MRI (contrast-enhanced T1-weighted and T2/FLAIR), which is unreliable. The emergence of advanced MRI techniques, MR spectroscopy, and PET tracers has improved pseudo progression diagnostic accuracy. This review presents a literature review of the different imaging techniques and potential imaging biomarkers to differentiate pseudoprogression from true progression.

Dates et versions

hal-03599517 , version 1 (07-03-2022)

Identifiants

Citer

Caroline Bund, Benjamin Leroy-Freschini, Roland Schott, Helene Cebula, Georges Noel, et al.. Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2-Radiological features and metric markers. Critical Reviews in Oncology/Hematology, 2021, 159, ⟨10.1016/j.critrevonc.2021.103230⟩. ⟨hal-03599517⟩

Collections

U-PICARDIE CHIMERE
12 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More